|
Volumn 14, Issue SUPPL. 1, 2014, Pages 11-44
|
OPTN/SRTR 2012 Annual Data Report: Kidney
a,b a,c a a a a,d e,f e,f e,f a,g a,b,g a,b |
Author keywords
End stage renal disease; Kidney transplant; Organ allocation; Waiting list
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DIALYSIS;
ECONOMICS;
END STAGE RENAL DISEASE;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEMODIALYSIS PATIENT;
HOSPITAL ADMISSION;
HOSPITAL READMISSION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY;
KIDNEY DONOR;
KIDNEY GRAFT;
LIVING DONOR;
MEDICARE;
OUTCOME ASSESSMENT;
PEDIATRIC SURGERY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REIMBURSEMENT;
SURVIVAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ADVERSE EFFECTS;
CHILD;
CYTOMEGALOVIRUS INFECTIONS;
DONOR;
EPSTEIN-BARR VIRUS INFECTIONS;
GRAFT REJECTION;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
REOPERATION;
STATISTICS AND NUMERICAL DATA;
SUPPLY AND DISTRIBUTION;
TRANSPLANTATION;
UNITED STATES;
ADOLESCENT;
ADULT;
CHILD;
CYTOMEGALOVIRUS INFECTIONS;
EPSTEIN-BARR VIRUS INFECTIONS;
GRAFT REJECTION;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
REOPERATION;
TISSUE AND ORGAN PROCUREMENT;
TISSUE DONORS;
TREATMENT OUTCOME;
UNITED STATES;
WAITING LISTS;
|
EID: 84893262380
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/ajt.12579 Document Type: Article |
Times cited : (286)
|
References (0)
|